PARATEK PHARMACEUTICALS, INC - ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
Key Details
Description
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
Context & Analysis
On Feb 19, 2026, Department of Health and Human Services obligated $265,316,226 to PARATEK PHARMACEUTICALS, INC for antibiotic for treatment of a biothreat indication. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 4 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BOSTON, MA. The contract is scheduled through Dec 17, 2029. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
OT TASK ORDER 2
ADVANCED TECHNOLOGY INTERNATIONAL
$120.3M
Stay Updated
Get notified about new opportunities matching your interests.